QuanterixQTRX -0.35%58 FCF Yield % is -40.78 as of Jul. 06, 2026. GuruFocus rates QTRX with a GF Score™ of 58/100 and a GF Value™ of $11.68 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 856 Medical Devices & Instruments companies, Quanterix ranks worse than 90.07% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Quanterix FCF Yield % Related Terms
Quanterix FCF Yield % Historical Data
* Premium members only.
The historical data trend for Quanterix's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Quanterix's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Quanterix FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Quanterix's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Quanterix's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Quanterix (QTRX) has a FCF Yield % of -40.78 as of Jul. 06, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Quanterix and its competitors. According to the industry distribution chart, Quanterix ranks #771 out of 856 companies in the Medical Devices & Instruments industry, placing it in the top 90.1%.
Is Quanterix's FCF Yield % too high?
Quanterix's current FCF Yield % is -40.78. Based on the distribution chart, Quanterix ranks #771 out of 856 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Quanterix has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Quanterix's FCF Yield % compare to LUCD and INFU?
According to the Medical Devices & Instruments industry distribution chart, Quanterix ranks #771 out of 856 companies for FCF Yield %. This places Quanterix in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Quanterix and its competitors. Quanterix's current FCF Yield % is -40.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quanterix stock overvalued right now?
Based on GuruFocus' analysis, Quanterix (QTRX) is currently considered Possible Value Trap. The stock's GF Value™ is $11.68, compared to a current price of $4.32 — trading 63.1% below its estimated fair value. The current FCF Yield % is -40.78. Quanterix's overall GF Score™ is 58/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Quanterix (QTRX), the current FCF Yield % is -40.78 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Quanterix (QTRX) Overvalued in 2026?
Based on GuruFocus' analysis, Quanterix stock appears to be undervalued.
The current stock price of $4.32 is trading 63.1% below its estimated GF Value™ of $11.68.
GuruFocus considers Quanterix to be Possible Value Trap.
Key valuation signals for QTRX:
FCF Yield %: -40.78
GF Value™: $11.68 vs. price of $4.32 (63.1% below fair value)
No single metric tells the full story. See the QTRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.
58GF Score
Get the complete analysis for QTRX
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
QTRX has been successfully added to your 
